Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease
- 1 August 1985
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 107 (2), 301-306
- https://doi.org/10.1016/s0022-3476(85)80156-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Clinical Pharmacokinetics of RanitidineClinical Pharmacokinetics, 1984
- Ranitidine: A New H2-Receptor AntagonistNew England Journal of Medicine, 1983
- Drugs Five Years Later: Cimetidine: I. Developments, Pharmacology, and EfficacyAnnals of Internal Medicine, 1982
- Drug Interactions with CimetidineClinical Pharmacokinetics, 1982
- ANTAGONISM OF VASODEPRESSOR AND GASTRIC SECRETORY RESPONSES TO HISTAMINE BY THE H2‐RECEPTOR ANTAGONISTS, RANITIDINE AND CIMETIDINE, IN THE ANAESTHETIZED DOGBritish Journal of Pharmacology, 1981
- Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.Gut, 1981
- Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.BMJ, 1980
- Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.Gut, 1980
- Inhibition of Gastric Secretion in Man with a New H2-Receptor Antagonist, RanitidineScandinavian Journal of Gastroenterology, 1980
- INHIBITION OF PENTAGASTRIN-STIMULATED AND NOCTURNAL GASTRIC SECRETION BY RANITIDINEThe Lancet, 1979